Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Cassava Sciences Stock Undervalued with Its $124 Price Target?
January 30, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
AZN
BIIB
LLY
MRK
TOP RANKED ROSEN LAW FIRM Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 29, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
YMAB
Dell Laser Consultants Announces Treatment of First Patient in Austin With the IC-8® Apthera™ IOL
January 27, 2023
Via
Newswire.com
Exposures
Product Safety
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Announces Pricing of ~$8.4M Registered Direct Offering and Concurrent Private Placement
January 27, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NMRD
Transforming Global Music Scape: Introducing International Pop Phenomenon Vibe Exclusive
January 23, 2023
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Ainnova Tech announces Dr. Maziar Lalezary, M.D. as Medical advisor and member of Medical Board
January 27, 2023
Via
Zexprwire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Skye Bioscience Obtains Central IRB Approval for Phase 2 Clinical Trial with SBI-100 Ophthalmic Emulsion
January 27, 2023
Via
Newsfile
Exposures
Product Safety
Tickers
SKYE
cbdMD Maintains Commitment to Advocating for FDA Regulation Despite Recent News
January 26, 2023
Via
Newsfile
Exposures
Product Safety
Tickers
YCBD
YMAB NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 26, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
YMAB
Report on 63 FDA-Approved Brand Names Released by Branding Agency, Brandsymbol
January 26, 2023
Via
Press Advantage
Exposures
Product Safety
Lobe Sciences, Ltd. Enters Collaborative Clinical Research Agreement with Integrative Headache Medicine of New York to Study the Effects of L-130 in the Treatment of Chronic Cluster Headache
January 26, 2023
Via
FinancialNewsMedia
Exposures
Product Safety
Tickers
CSE:LOBE
LOBEF
Mergers and Acquisitions in 2023 Off To A Strong Start
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
AZN
BNTX
CVS
GILD
How Could GSK's RSV Vaccine Change its Valuation?
January 26, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
GSK
MRNA
PFE
BioMedNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Advances Novel Drug Candidate in Treating Alzheimer’s Symptoms
January 25, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
IGC
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
January 25, 2023
Via
MarketBeat
Topics
Workforce
Exposures
Layoff
Product Safety
Tickers
EDIT
ELEV
FATE
IPSC
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Doses First Participants in PH10 Phase 1 Clinical Trial
January 24, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VTGN
InvestorNewsBreaks – Nemaura Medical Inc. (NASDAQ: NMRD) Reports Promising Initial Results from UK NHS Miboko Study
January 24, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
NMRD
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
January 24, 2023
Via
NewMediaWire
Topics
Cannabis
Economy
Lawsuit
Exposures
Cannabis
Financial
Legal
Tickers
MJNA
AMC Health Announces Appointment of Chief Operating Officer
January 24, 2023
Via
Newswire.com
Exposures
Product Safety
Mental Health Clinic Offering Transcranial Magnetic Stimulation in Santa Rosa Welcomes RN Paula Davey to the Team
January 23, 2023
Via
Press Advantage
Exposures
Product Safety
BioMedNewsBreaks – QSAM Biosciences Inc. (QSAM) to Present at Emerging Growth Conference
January 23, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
QSAM
Wandercraft Receives FDA Clearance for Atalante, a Self-Balancing Device for Hands-Free Movement
January 23, 2023
Via
Newswire.com
Exposures
Product Safety
BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) NanoAb May Serve as Therapeutic and Prophylactic as Shown in Preclinical Study
January 23, 2023
Via
Investor Brand Network
Exposures
COVID-19
Product Safety
Tickers
BVXV
ROSEN, A TOP RANKED LAW FIRM, Encourages Y-mAbs Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - YMAB
January 22, 2023
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Tickers
YMAB
Feline Fortune? Saint Julian Corey Van Hannegeyn IV went from $10,000 to $10,000,000 with Bizarre Inspiration from Stray Cats
January 19, 2023
Via
AB Newswire
Topics
Artificial Intelligence
Product Recall
Exposures
Artificial Intelligence
Legal
Product Safety
InvestorNewsBreaks — VistaGen Therapeutics Inc. (NASDAQ: VTGN) Set to Commence Antidepressant Nasal Spray Trial This Quarter
January 19, 2023
Via
Investor Brand Network
Exposures
Product Safety
Tickers
VTGN
Moderna and Pfizer Race to Release RSV Vaccines
January 19, 2023
Via
MarketBeat
Exposures
Product Safety
Tickers
MRNA
PFE
Acurx Is Vying for Standard of Care in Treating Primary and Recurrent C. diff
January 19, 2023
Via
TheNewswire.com
Topics
Death
Exposures
Death
Product Safety
Tickers
ACXP
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
January 19, 2023
Via
FinancialNewsMedia
Exposures
COVID-19
Product Safety
Tickers
AZN
CRDF
CYAD
RIGL
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
January 19, 2023
Via
News Direct
Exposures
Product Safety
Tickers
VTGN
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.